1 completed, 1 withdrawn. 2 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 2 | Completed 1, Withdrawn 1 |
Follow R-CHOP protocol: new trials by email Literature Review of R-CHOP protocol trials Research Report on R-CHOP protocol
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Study of Treatment ALK(+) Systemic Anaplastic Large Cell Lymphoma With Crizotinib crizotinib - Systemic Anaplastic Large-Cell Lymphoma | Phase 4 | Withdrawn | Jun Zhu | 2015-07-01 | 2016-12-30 | |
| LINFOTARGAM: Treatment With Chemotherapy Plus Rituximab and Highly Active Antiretroviral Therapy in Patients With Diffuse Large B Cell Lymphoma and Infection With the Human Immunodeficiency Virus (HIV) R-CHOP, Highly active antiretroviral therapy, Central nervous system (CNS) prophylaxis - HIV Infections, Diffuse Large B Cell Lymphoma | Phase 4 | Completed | PETHEMA Foundation | 50 | 2006-10-01 | 2009-11-25 |
HIV Infections (1) · Lymphoma, Large B-Cell, Diffuse (1) · Lymphoma, Large-Cell, Anaplastic (1)
Jun Zhu (1) · PETHEMA Foundation (1)
China (1) · Spain (1)
Jun Zhu, MD (1) · Oriol Albert, Dr (1) · Ribera Josep M, Dr (1)